My comrade Amir Hassanpour lay helpless on the hospital bed,
IV tubes and tracheal tubes in place.  He had just been wheeled
into Intensive Care after emergency removal of a cancerous
tumor on his first vertebra.  Two bright-eyed young orderlies
approached asking him to participate in a study of transition
from emergency to ICU.  Amir couldn't speak at all, breathing
was hard enough; he got a paper and pencil and wrote his answer
to them: "Who is financing your research?"  They were surprised,
as you may imagine, so he amplified: "If your study is financed
by a pharmaceutical company I won't take part."  (It wasn't.)
 			Chandler